Implementation has to be finished till February, 9th 2019

Press release

In Prague, on 13 July 2017

The National Medicines Verification Organization (NMVO) chose Solidsoft Reply as a provider of the national IT system for medicines verification.

Starting in February 2019, all prescription medicinal products shall be required to bear a two-dimensional code that shall make it possible to verify the authenticity of their packaging upon dispensing. The medicines verification system required by European legislation is being implemented in the CR by the newly founded National Medicines Verification Organization (NMVO) that has just chosen the IT solution provider.

Solidsoft Reply, which has been operating on the market since 1993 and specializes in cloud solutions, won the tender for a comprehensive contract that includes the implementation and five-year operation of the national information system. The company is Microsoft’s certified “golden” partner that uses the Microsoft Azure platform for its solutions and one of so-called blueprint providers, i.e. one of the companies recommended by the European Medicines Verification. Organization (EMVO) to implement IT solutions for the medicines verification system in individual EU States. 

“We found Solidsoft Reply’s solution to be effective, in compliance with legislative requirements and yet not too complicated. We trust that the new system shall improve the credibility of the entire distribution chain in the eyes of patients and shall prevent falsified or stolen medicines from entering the distribution chain,” said Mgr. Jakub Dvořáček, MHA, the chairman of the Board of Directors of the NMVO.

The national medicines verification systems shall be connected to the European central system, the so-called hub. Solidsoft Reply also provides and shall continue to operate this hub. The Czech Republic thus can be sure that the national system shall be compatible with the European system.

The entire project is in fact unprecedented: the European Union create a regulatory requirement and left its implementation and financing up to the regulated entities, i.e. the pharmaceutical industry, the distributors of medicinal products and pharmacies. Pharmaceutical companies associated in the Association of Pharmaceutical Industry (AIFP) and the Czech Association of Pharmaceutical Companies (ČAFF) bear an absolute majority of the cost of implementation of the system. Pharmacies shall incur huge costs due to the operation of the system – the purchase of scanners, the modification of pharmacy programs and a personnel increase due to more paperwork.  

Founding members

Associate members

© Copyright 2019 Národní organizace pro ověřování pravosti léčiv, z.s
editorial system Kompletweb | Neofema, s.r.o.